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Computer simulations have been used to model infectious diseases to examine the outcomes of alterna-
tive strategies for managing their spread. Methicillin resistant Staphylococcus aureus (MRSA) skin and soft
tissue infections have become prominent in many communities and efforts are underway to reduce the
spread of this organism both in hospitals and communities. Currently, there are few tools for policy mak-
ers to use to examine the outcome of various choices when making decisions about MRSA. Using the
example of MRSA, we describe, in this paper, a rigorous approach for development and validation of a tool
that simulates the spread of MRSA infections. We used sensitivity analyses in a novel way and validated
the simulation results against local data over time. Our approach for simulation development and valida-
tion is generalizeable to simulations of other diseases.
 2010 Elsevier Inc. All rights reserved.1. Introduction
The well deﬁned mathematics of epidemic spread makes infec-
tions amenable to study through the use of simulation models.
Tuberculosis [1], AIDS [2], and inﬂuenza [3] are among the infec-
tions whose spread has been studied using simulation, primarily
for the purpose of determining the best strategies for control in
communities. Development of simulation models requires a clear
understanding of the parameter values, a mathematical model
which relates the parameters in a meaningful way, and reliable
data on the disease incidence or prevalence.
Deterministic, stochastic, and agent-based models [4–7] have
all been used to model infectious disease; the choice of the partic-
ular model type is determined by the speciﬁc research question,
the parameters which are known, and the expertise and tools avail-
able to the researcher. Because stochastic models give outcomes
with a probability distribution, they are more useful for diseases
where the clinical course demonstrates a great deal of variation,
or where the prevalence in the community is so low that stochastic
events can signiﬁcantly impact outcome. Diseases such as HIV may
require stochastic models for both of these reasons [8]. Agent-
based models can be used to model nonhomogenous spread in
communities. Care must be taken not to add complexity unneces-
sarily because, if not all parameter values are known, estimation
can decrease the validity of the model. Deterministic models arell rights reserved.
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. Panchanathan).most frequently used because of their relative simplicity and their
history of use, though care must be taken to avoid assumptions
that oversimplify the representations of the diseases. Deterministic
equations can also act as a basis for a model with stochastic
modiﬁcations as used to study the spread of respiratory syncytial
virus [9].
The basic structure of the SIR epidemic model is a deterministic
model. It and its numerous variations have been described else-
where [10,11]. The speciﬁc variation to be used in any model must
take into account the clinical realities of the infection being mod-
eled. Models thus account for such clinical features as the existence
of a resistant state, an exposed state, and passive maternal immu-
nity. In addition, the transitions between each of these states are
affected by risk factors which also need to be included. Thus, every
infection must have its own model uniquely developed and vali-
dated, with the understanding that infectious diseases are con-
stantly evolving with respect to important parameters such as
contagiousness and infectivity. For this reason, validation must
be an ongoing process.
Many studies describing and using simulations have focused on
the conclusions without clearly addressing the underlying issue of
the validity of the model [12–14]. Unal et al. [15] reviewed 42
models of coronary artery disease policy and determined that a
good model requires (1) high quality data to create the model
(with methods used to address deﬁciencies in the data made expli-
cit), (2) explicit assumptions, and (3) adequate detail for replica-
tion. We propose that, while not necessary to create a good
model, validation is required to demonstrate that a model is good.
In addition, having explicit literature sources for the various
S.S. Panchanathan et al. / Journal of Biomedical Informatics 43 (2010) 602–607 603parameter values is important because some parameters may be
affected by the prevalence of risk factors in different geographic
locations.
Having high quality data, explicit assumptions and sufﬁcient
detail for replication is particularly important in simulation of
infections. The compounding nature of the mathematical equa-
tions in epidemic spread causes small errors in the assignment of
parameter values to propagate over time and result in large dis-
crepancies with observed phenomena. In this paper, we describe
the process of building a simulation model starting with the
assignment of parameter values from the literature, the use of local
data to the modify parameters values using a subset of the data,
and validation of the model using the remainder of the data.2. Background
The past ten years has seen a signiﬁcant increase in skin and soft
tissue infections (SSTI’s) causedbymethicillin resistant Staphylococ-
cus aureus (MRSA) in theUnited States [16,17]. These community ac-
quired MRSA (CA-MRSA) infections cause abscesses requiring
surgical drainage with a greater frequency than their methicillin
sensitive counterpartsandaredistinct fromhospital-acquiredMRSA
(HA-MRSA) infections that have been described earlier. Recent re-
search has focused on identiﬁcation of populations at a high risk of
MRSA infection [18–20] in an attempt to ﬁnd targeted strategies to
control the spread of this organism. A recent study fromBoston used
a deterministic model to examine the replacement of HA-MRSA by
CA-MRSA as a signiﬁcant hospital pathogen [4]. The goal of that
model was to simulate the competition between the two organisms
in a hospital environment and assess the resulting shift in type of
nosocomial infection.Hence thatmodel is not applicable to simulate
the spread of community MRSA infections.
This paper reports the development of a simulation of MRSA
spread that has been validated against population data. We pro-
pose this rigorous method as a generalizeable approach to develop-
ment of a valid simulation, that can then be used to inform public
health policies. Our method also has the potential for elucidating
the relative contributions of various parameters, particularly those
which do not have values in the literature.3. Methods
The SEIS (susceptible-exposed-infected-susceptible) model is a
deterministic model of epidemic spread that is applicable for infec-
tions: (1) for which there is no resistant state following resolution
of infection; and (2) which have a period of latency prior to devel-
opment of clinical infection. These characteristics ﬁt the current
knowledge about MRSA. The equations of the SEIS model describe
the changes in numbers of people in the three compartments (sus-
ceptible, exposed, and infected) within a population of interest. We
chose a deterministic model because the high prevalence of this
infection decreases the effect of stochastic events and the relative
uniformity of the course of this infection makes the probability dis-
tribution of the outcome likely to be narrow. We make the
assumption of homogenous spread because, in this region, the
infections were spread geographically throughout the area under
consideration.
We used a SEIS framework to model MRSA. Parameters were
obtained from two different sources:
(1) Literature about MRSA, speciﬁcally focused on the preva-
lence of colonization, infectivity, contagiousness, and decol-
onization. For each parameter, a range of possible values
based on the literature was obtained and a single ‘‘best”
estimate was selected.(2) Primary data. Primary data, described in detail below, were
obtained from a research data repository maintained and
managed by the Center for Health Information and Research
as Arizona State University.
3.1. Data sources
The Center for Health Information Research (CHIR) is a univer-
sity–community partnership between ASU and several Arizona
providers, insurers and employers. It maintains a research data
repository that integrates Arizona-based administrative, clinical,
and public health data across a large number of sources permitting
the conduct of population-based research on residents of Arizona.
Our study used CHIR data on hospitalization and outpatient visits
of children and youth (age < 19 years) who were continuously en-
rolled for at least 6 months in the Arizona Healthcare Cost Contain-
ment System (Medicaid) program during the period 2001–2008.
We recognized that the use of this population would likely tend
to overestimate the MRSA incidence in the community because
the population has demographic characteristics known to be asso-
ciated with high MRSA risk. However, the data available on this
population represents a higher quality and readily accessible com-
puter-stored information for the variables used.
The records of all pediatric (age < 19 years) encounters with a
diagnosis code representing skin or soft tissue infection (ICD-9
codes 680.xx–682.9x) from 2001 to 2008 in Maricopa County were
extracted from the data repository. An encounter was eligible for
the analysis if it occurred in a patient at least >30 days after a prior
qualifying soft tissue infection encounter in an attempt to identify
newly occurring infections and avoid inclusion of followup visits
for a previously identiﬁed infection. All encounters were also spe-
ciﬁcally categorized according to whether they represented multi-
ple instances in the same patient and whether they were multiple
infections in different people living at the same address. Demo-
graphic information and zip code were extracted from the data
repository for each encounter.
On detailed examination of the datasets for each year, we real-
ized that the quality of data for the years before 2004 was incom-
plete and markedly inferior to that of the later years. This was
identiﬁed by the fact that there were signiﬁcantly fewer records
for those years, and the age distribution differed from Medicaid
membership. The data for the years 2001–2003 was therefore, dis-
carded. The remaining data from 2004 to 2008 consisted of
1536,836 records with 34,997 instances of SSTI.
Information regarding the prevalence of methicillin resistance
in staphylococcal isolates in the community was obtained from
statistics on wound cultures submitted from 3 urban emergency
departments in the Greater Phoenix area.
The CHIR data, along with the MRSA prevalence in the commu-
nity was used to determine the monthly target numbers of infected
people in the population for our simulation. The years from 2004 to
2006 were used to develop the model and the data from 2007 and
2008 were used for validation. The use of data for validation that
was not used to build the simulation permitted detection of over-
ﬁtting of the model to the data.
3.2. Simulation model
The SEIS equations were used as the basis of a Java program
written speciﬁcally for this project. The assumption was made that
susceptible individuals cannot transition directly to the infected
state and vice versa; this appears to be supported by the clinical
evidence. The equations were modiﬁed to reﬂect known informa-
tion about MRSA and Maricopa County. We added parameters to
reﬂect that: (1) only a fraction of the total number of patients
entering the colonized (exposed) state become infected, (2) the
Fig. 1. Schematic depiction of the compartments with equations deﬁning movement between the compartments.
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infection, and (4) the average local immigration rate was 3.5% per
year in Maricopa County during the time under consideration.
Approximate values for the various parameters were obtained
from the literature and used to build the simulation. A period of
1=4 month was used as the unit of time for the simulation.
The movement between the susceptible, colonized and infected
compartments for each month was deﬁned by the equations
shown in Fig. 1 below, where S, C, I, and N are the number of sus-
ceptible, colonized, infected, and total individuals in the popula-
tion, b is the contagiousness of an infected person, f is the
relative contagiousness of a colonized person, d is the fraction of
colonized people who spontaneously decolonize, td, is the time
to decolonization, b is the infectivity, r is the fraction of individuals
in the population with a previous MRSA infection, s is the addi-
tional risk conferred by previous infection, and ti is the duration
of infection.
Further analysis of the equations reveals that the conversion
from susceptible to colonized consists of two components, people
who are colonized by contact with infected individuals and those
who are colonized through contact with colonized individuals.
The conversion from colonized to infected also consists of two
components, reﬂecting a general rate of infectivity for those indi-
viduals without a previous infection and a higher rate of infectivity
for those with a previous infection. The conversion between in-
fected and colonized is dependent only on the length of time it
takes to fully treat, and the conversion from colonized back to sus-
ceptible is dependent on the proportion of individuals who sponta-
neously decolonize and the median length of time they take to
decolonize.Table 1
Summarizes the values of the parameters used and the ranges tested in the sensitivity an
Parameter Value
Contagiousness-infected (b) 0.3
Contagiousness factor-colonized (f) 0.25
Decolonization fraction (d) 0.6
Time to decolonization (td) in months 7
Infection time (ti) in months 1
Infectivity (b) 0.035
Fraction with previous infection (r) 0.17
Relative risk due to previous infection (s) 2.53.3. Assignment of parameter values
The initial values for the parameters used in the model were de-
rived from the literature, and we adjusted these to be consistent
with the data from 2004 to 2006 during the model construction
phase (Table 1). The data from 2007 and 2008 were used during
the validation phase to examine the robustness of the model and
to understand any deviations from the model.
The infection time, ti, is not explicitly stated in the literature.We
assigned a value of 1 month, taking into account the time delay in
seekingmedical attention, and assuming that two courses of antibi-
otics are required, since it is only in the past few years that initial
treatment for presumed MRSA has become standard. The median
time of decolonization, td, was assigned a value of 7 months and
the spontaneous decolonization fraction, d, a value of 0.6 based on
the literature [21].
Though the contagiousness of a single contact with a MRSA-in-
fected patient has been described as 17% [22], one has to assume
that the contagiousness of the patient over a length of time will
be more. However, the prevalence of colonization in family mem-
bers of infected individuals is only 13% [23]. Therefore, the conta-
giousness of an infected person, b, was given a value of .3 per
month. With 60% decolonization, the 40% remaining colonized
results in 12% (0.30.4) prevalence of colonization in household
contacts which is consistent with the literature.
The fact that contact with health care workers is an indepen-
dent risk factor for development of MRSA infections [24,25] implies
that the colonized state is contagious. It is not known how conta-
gious the colonized state is with respect to the infected state and
therefore this value, f, was estimated using sensitivity analysis ofalysis.
Range References
0.2–0.5 [22,23]
0–0.5 [24,25] – ﬁtted to CHIR data – see text Section 3.3
0.4–0.8 [21]
1–18 [21]
0.25–1.5 Estimated from clinical course
0.01–0.15 [26] – ﬁtted to CHIR data – see text Section 3.3
n/a Observed in data extracted from CHIR
1–8 [25]
Fig. 2. Average monthly skin and soft tissue infections (SSTI) and MRSA infections
in dataset, with simulation model results superimposed on MRSA numbers.
Fig. 3. Sensitivity analysis of the contagiousness factor, f, of colonization with
respect to infection. Note that the curve for f = .25 most closely approximates the
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0.25 was assigned following comparison with CHIR data.
The percentage of previous MRSA infections was derived from
the data abstracted from the CHIR dataset. In 2004, the data showed
83% of the infections were ﬁrst time infections. This percentage
decreased by approximately 2.5% per year in each subsequent year.
The relative risk conferred by previous infectionwas estimated to be
2.5 and tested in the described range is 1.98–8 [25].
The infectivity, b, was initially given a value of 0.15 per month
based on a 10 week study of US army soldiers undergoing basic
training [26]. However, it was found that this led to a greater rise
in the infection prevalence than was observed in the data, and it
is suspected that abrasions acquired during basic training may
have signiﬁcantly increased the infection rate in that study. A ﬁnal
value of .035 was assigned to this parameter in order to ﬁt with the
observed rate of increase.
Finally, the initial colonization prevalence was assigned a value
of 2% corresponding to the prevalence of colonization elsewhere
[27–29] in the United States during this time. Though there is no
local prevalence data on colonization with MRSA, there is currently
a study in the Phoenix and this data will be used to further validate
our model.
Since the CHIR data represents incidence rates, and the simula-
tion model resulted in prevalence numbers, they were equated by
dividing the prevalence by the duration of infection to obtain inci-
dence rates. This was particularly important when examining the
effect of altered infection time, since changing this parameter
changes the duration of disease and the target numbers.
3.4. Sensitivity analysis
Each parameter was tested within its plausible range of values
and the effect on the outcome examined. There were three pur-
poses for the sensitivity analyses. The ﬁrst purpose was to assign
values to unknown parameters. The second was to determine if
the value described in the literature was consistent with the local
data and if not, which value of the parameter was consistent. The
ﬁnal purpose was to examine the parameters which can be altered,
to determine the quantitative impact of potential interventions.
The sensitivity analyses also showed the effect that incorrectly
chosen values would have on the overall model.
3.5. Validation
We built the simulation model using data from 2004 to 2006
and validated it against years 2007 and 2008. In this manner, one
set of data was used to build the model and another set was used
for validation. Because infectious diseases have the potential to
change over time, validation over time ensures the ongoing rele-
vance of the model for public policy decision making.data.
Fig. 4. Sensitivity Analysis of Infectivity, b. Note that the value of .15 of this
parameter from the literature grossly overestimates the expected number of
infections.4. Results
Fig. 2 gives the average number of monthly skin and soft tissue
infection cases from the year 2004 to 2007 in Maricopa County.
The percentage of infections caused by MRSA was 46.3, 47.8, 46,
43.1, and 41.8% respectively in 2004–2008 and the resulting MRSA
infection numbers are also shown in the graph. These represent the
target numbers against which the simulation model was validated.
The performance of the simulation is superimposed on the MRSA
numbers.
Sensitivity analysis was used in three ways during the creation
and use of this model. The ﬁrst use was to determine the value of
unknown parameters. The second was to determine the value of
parameters whose value in the literature was not consistent withthe available data. Finally, sensitivity analysis was used in its tradi-
tional role to assess the impact of modifying parameter values. The
results of the sensitivity analysis for each of these purposes are
shown.
The sensitivity analysis of contagiousness factor, f (an unknown
parameter of the colonized individual with respect to the infected
individual) is presented in Fig. 3. We noted that even if the colo-
nized state is a third as contagious as the infected state the number
of infections rise at a greater rate than observed. When the colo-
nized individual is assumed not to be contagious (f = 0), the infec-
tion extinguishes in the population quickly.
The sensitivity analysis of infectivity, b, (a parameter whose va-
lue in the literature is given as .15) is presented in Fig. 4. We noted
that when this value is used, the number of infections rise at a
greater rate than observed. When the value is assumed to be
.035, which is one-third of that value, the number of infections rise
at a rate consistent with the population data.
The sensitivity analysis of the decolonization fraction is shown
in Fig. 5. It is possible to increase decolonization fraction through
decontamination of the patient following treatment. The simula-
tion results show that even a modest increase in the decolonization
fraction results in a decrease in infections in the community.
Fig. 5. Sensitivity analysis of decolonization fraction. Note that even a modest
increase in the number of decolonized individuals leads to decreased infections.
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a 10% decrease (from .3 to .27) in this parameter led to a decrease
in number of infections in the community. The model was not sen-
sitive within the time frame studied to the relative risk of previous
infection, s. However, it is expected that this parameter’s effect
would largely be noted in later years, as the fraction of individuals
with recurrent infection continue to rise.5. Discussion
We have described a systematic approach to the development
of a simulation model for soft tissue infections that was validated
to local data with explicit modiﬁcations of parameters as required
for consistency with observed data. The ﬁtting of the model to the
empiric data (Fig. 2) makes the simulation model more useful lo-
cally, while the explicitness of the changes allows researchers in
other locations to decide whether or not these modiﬁcations apply
in their communities. We found that sensitivity analysis helped us
to deﬁne unknown parameters (Fig. 3), choose the correct value of
a parameter with a range in the literature (Fig. 4), and give a quan-
titative metric for the impact of changing the value of a parameter
(Fig. 5). The approach to development and validation of a simula-
tion model such as the one described here, as well as the validity
of any conclusions, is highly dependent on the quality of the under-
lying data from which it is derived. In this study, care was taken to
ensure the integrity of the data that were used to build the model.
In addition, assumptions, the assignment of parameters and the
reasons for adjustments were explicit, which makes it possible
for others to examine the validity of the model prior to its use.
The parameters which had values given in the literature, with
the exception of infectivity, fell within the range described.
The use of sensitivity analysis in multiple ways is one of the un-
ique features of our model development. We used sensitivity anal-
ysis in its traditional way, to determine the effect of different
values of parameters on the outcome. However, somewhat un-
iquely, we also used sensitivity analysis and comparison with data
to determine the value of parameters whose value was unknown
and to determine the value of a parameter whose value in the lit-
erature did not result in the outcomes seen in the data. Thus, we
were able to estimate values for these parameters. This method ad-
dresses one of the major difﬁculties in simulation building, which
is the question of how to deal with parameters whose values are
unavailable or inconsistent with the data. Not all parameter values
described in the literature are equally applicable in all populations,
and validation with local data ensures the usefulness of the simu-
lation for local policy decisions.
There are several other unique features to our method of simu-
lating infection spread. We explicitly addressed the quality of the
data that was used to build and validate the model. We also vali-
dated the model over time with data that was not used to build
the model in order to assess its ongoing relevance. This last featureis particularly important as it lends credibility to the use of the
model for policy decision making. Infectious diseases are con-
stantly evolving and therefore, there is the potential for the simu-
lation to become less valid over time if care is not taken to continue
to establish its robustness.
Our approach to building a high quality simulation for this con-
dition can be generalized to other domains where empiric data are
available. In our work, we reviewed the literature to deﬁne initial
parameter values, carefully examined the data to ensure its quality
and then used a subset of that data to reﬁne the parameter values
using sensitivity analyses. Sensitivity analysis played a signiﬁcant
role in deﬁning parameters whose values were unknown. Finally,
we used the remainder of the data to validate the model.6. Conclusion
In conclusion, simulation is a valuable tool which has the poten-
tial for signiﬁcantly improving the decision making process, by
making available better information on which to base the policy
decisions. Using the example of MRSA, we describe a systematic
method for building a high quality simulation model and the vali-
dation of this model against population data. We have thus devel-
oped a strong framework in which to build future extensions for
policy and decision makers.
Our process of explicitly stating the data sources, the origin of
parameter values, and the scientiﬁc theory underlying the model
resulted in a simulation which can be easily assessed for its appli-
cability in other settings. Though our paper described simulation
modeling for spread of infection, we feel that the rigorous method
we used is applicable to the development of any simulation to im-
prove its quality and by extension, the quality of the conclusions
which can be drawn.
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